Narrowing in on the cause of kidney disease opens a whole new world of treatment options.
Our precision medicine product engine is the foundation of our approach. Our product engine allows us to discover and validate novel targets aimed at understanding the molecular and phenotypic heterogeneity in diverse patient populations to identify subsets most likely to respond our treatments.